Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma
Clinical trial NCT07018037 · RECRUITING
Trial details
- NCT number
- NCT07018037
- Sponsor
- Regina Elena Cancer Institute
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-01-29
- Primary completion
- 2026-01-29
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.